Company intelligence / Profile preview

Alliance Foundation Trials

Boston, Massachusetts, United States

Ownership: Private
Employees: ~46
Development stage: Other

Overview

Alliance Foundation Trials (AFT) specializes in designing and conducting cancer clinical trials in partnership with pharmaceutical companies and academic collaborators, with active programs in gynecological and other oncology indications, including the recent AFT-50 EndoMAP Phase 1b/2 umbrella study in endometrial cancer. Current clinical results are not specified, but AFT is known for efficient and scientifically rigorous multi-center studies, often as a bridge between academic and industry trials.

Therapeutic areas: Oncology
Industry: Contract Research Organization

Partnerships

Genentech

Beyond the preview

Go deeper on Alliance Foundation Trials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alliance Foundation Trials.

Explore the full profile